Mike Falduto

Mike Falduto has extensive work experience in the field of genomics and bioinformatics. Mike is the Chief Technology Officer and Co-Founder of Paradise Genomics since 2011 and GenUs BioSystems, Inc. since 2002. Prior to that, Mike worked at Abbott for nine years, where they served as a Senior Scientist in both the Diagnostics division and the Pharmaceutical Drug Discovery division. Mike'sresponsibilities at Abbott included utilizing genomics and gene-based assays to search for new molecular targets for cancer therapeutics. Mike also conducted research in the molecular biology of Alzheimer's disease, neurodegeneration, and immunology.

Mike Falduto has a Bachelor of Science (BS) degree from Arizona State University. Mike also holds a Doctor of Philosophy (PhD) degree in Physiology and Biophysics from the University of Illinois Chicago. Additionally, they have completed a post-doctoral program in Molecular Biology at Northwestern University.